Author: Rutali Thakur

Gaslighting occurs in a relationship when one person is made to feel manipulated and questions their reality. Medical gaslighting takes place when a patient’s concerns about their health are dismissed, minimized or they do not feel heard. The invitation to write an editorial about gaslighting in gastroenterology comes at an interesting time when resources in medical settings are extremely limited, affecting both patients and providers.

Read More

AGA released a new Clinical Practice Update providing commentary to help navigate and incorporate telemedicine into your gastroenterology practice. Telemedicine has been a valued component of some gastroenterology practices for years. However, the use of telemedicine increased abruptly in mid-2020, as individual and population-wide safety concerns during the COVID-19 pandemic accelerated demand from both patient and provider communities, and third-party payers removed barriers to reimbursement. Although telemedicine visits have fallen and in-person visits have increased gradually since the initial wave of COVID-19 in 2020, telemedicine remains an important format for ambulatory care, and is likely to persist long after the current pandemic…

Read More

Gastroenterologist income is up 11 percent in the last year, reaching $501,000 annually, according to Medscape’s 2023 “Physician Compensation Report” published April 14, which surveyed more than 10,000 physicians across 29 specialties. Gastroenterologists saw the second largest jump in pay, behind oncologists. Here are six additional things to know about gastroenterologists in 2023: 1. The average physician specialist pay was $382,000, $119,000 lower than GI pay. 

Read More

Biosimilar use might be lagging in gastroenterology compared to other specialties. Some potential reasons is that patients with gastrointestinal diseases like inflammatory bowel disease (IBD) might not be as comfortable switching to a medication when the originator is working, even if it results in a cost savings. In an interview with HCPLive®, Jordan E. Axelrad, MD, MPH, NYU Langone, and David P. Hudesman, MD, Medical Director of the Inflammatory Bowel Disease Center at NYU Langone Health, discussed the history of using biosimilars in IBD. “I think gastroenterologists probably came to the biosimilar conversation a bit later than our rheumatology colleagues where they have more therapeutics,”…

Read More

New York, NY — April 11, 2023 — Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, today announced that it has raised $30 million in Series B funding led by Koch Disruptive Technologies (KDT) and joined by existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures. This funding will bolster the company’s market leadership and momentum, as its recent clinical study results are driving accelerated contracting with payers and employers to reimburse access to Oshi Health as a covered benefit. The rigorous clinical trial of Oshi Health’s differentiated clinical model, conducted by a national health plan in…

Read More

Owlstone Medical has announced the launch of OMED Health, a dedicated, patient-centric brand and digital platform that will offer patients and clinicians access to breath-based diagnostic tests, point-of-care devices and support resources for a range of conditions. Initially focused on digestive disease, OMED Health will help individuals with gut health issues have an improved quality of life by enabling better, and faster, understanding and management of their conditions.

Read More

It takes a minute to find the Austin offices of Noah Kraft and Lucas Kraft, the red-headed brothers behind Wonderbelly, a new antacid heartburn reliever. They’re tucked up on the attic floor of a historic building on the city’s East Side, where startups like this one share real estate with new condos and veteran bars. Colorful rugs and a slew of Mac-topped desks dress up the low-ceilinged rooms, and evidence of late nights—a 12-cup coffee maker, a microwave, and bags of takeout—lurk in the corners. It’s exactly the kind of “before” office that the Kraft brothers might remember with nostalgia if…

Read More

BOSTON, April 10, 2023 /PRNewswire/ — Published today, Bain & Company’s 12th annual Global Healthcare Private Equity and M&A report reflects the continued resilience of the healthcare industry, with 2022 seeing near-record levels of healthcare dealmaking, in terms of both volume and value. Despite a slowdown caused by macro-economic and geopolitical forces in the second half of the year, 2022 was still the second-best year on record for healthcare dealmaking, due in large part to the white-hot pace of investment at the start of the year. Total disclosed deal value reached nearly $90 billion, down from $151 billion in 2021…

Read More

In 2023, there have already been several updates to guidelines and recommendations in gastroenterology care from ACG and AGA, including managing celiac disease, acute lower GI bleeding, ulcerative colitis and diagnosing biliary strictures. Additionally, the ACG revamped recommendations for management of subepithelial GI lesions and, most recently, published a clinical practice update on management of patients with alpha-gal syndrome, which manifests with common GI symptoms and is caused by Lone Star tick bites.

Read More